跳至主要内容
临床试验/CTRI/2023/10/058321
CTRI/2023/10/058321尚未招募2 期

Efficacy and safety of oral eltrombopag in reduction of bleeding and platelet transfusion in pediatric acute lymphoblastic leukemia: A double blinded placebo-controlled trial - NI

AIIMS, Bhubaneswar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • SGOT/SGPT < 3 times upper limit of normal and serum bilirubin < 2 mg/dL
  • Normal cardiac and renal functions
  • Written informed consent

排除标准

  • a. Relapsed acute lymphoblastic leukemia and lymphoma
  • b. Mixed phenotype acute leukemia
  • c. Presence of hemodynamic compromise requiring vasoactive support at enrolment
  • d. Presence of respiratory failure at enrolment
  • e. Received therapy prior to presentation at treating centre (Excluding steroids up to 7 days)
  • f. Hepatitis B/ C infection
  • g. Known thrombophilia

研究者

相似试验